Oral sildenafil versus bosentan for treatment of persistent pulmonary hypertension of the newborn: a randomized controlled trial
Abstract Background Access to inhaled nitric oxide (iNO) is limited in low resource settings due to non-availability and high cost. There is a need for research on low-cost alternative therapies for management of persistent pulmonary hypertension of the newborn (PPHN). We aimed to compare oral silde...
Saved in:
Main Authors: | Aditya Kallimath (Author), Sujata Deshpande (Author), Pari Singh (Author), Reema Garegrat (Author), Satyan Lakshminrusimha (Author), Rajesh Maheshwari (Author), Pradeep Suryawanshi (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Persistent Pulmonary Hypertension in the Newborn
by: Bobby Mathew, et al.
Published: (2017) -
Management of neonatal pulmonary hypertension-a survey of neonatal intensive care units in India
by: Pari Singh, et al.
Published: (2023) -
Randomised controlled trial to compare the effect of PIOMI (structured) and routine oromotor (unstructured) stimulation in improving readiness for oral feeding in preterm neonates
by: Pari Singh, et al.
Published: (2023) -
Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
by: Pierangelo Chinello, et al.
Published: (2011) -
Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial
by: Chinmay Chetan, et al.
Published: (2022)